| Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) | 
|---|
| 11/13/2003 | US20030212269 Kinase inhibitor; antitumor agents, psoriasis, skin disorders, antiarthritic agents | 
| 11/13/2003 | US20030212120 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders | 
| 11/13/2003 | US20030212111 Controlling concentration of cholesterol, triglyceride, bile acid | 
| 11/13/2003 | US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents | 
| 11/13/2003 | US20030212066 1-Sulfonyl pyrrolidine derivatives | 
| 11/13/2003 | CA2484597A1 Thiazolidinones and the use thereof as polo-like kinase inhibitors | 
| 11/13/2003 | CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity | 
| 11/12/2003 | EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use | 
| 11/12/2003 | EP1359892A1 Primary intermediates for oxidative coloration of hair | 
| 11/12/2003 | EP1240164B1 Benzazole derivatives and their use as jnk modulators | 
| 11/12/2003 | EP0861243B1 Heterocyclic compounds as bradykinin antagonists | 
| 11/12/2003 | CN1455767A Substituted phenylcyclohexane carboxylic acid amides and use thereof | 
| 11/11/2003 | US6646162 Compounds and compositions for delivering active agents | 
| 11/11/2003 | US6646128 Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives | 
| 11/11/2003 | US6646122 Ligand and complex for catalytically bleaching a substrate | 
| 11/11/2003 | US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases | 
| 11/11/2003 | US6645987 Thrombin receptor antagonists and binders to cannabinoid receptors | 
| 11/11/2003 | US6645970 Preventing T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer | 
| 11/11/2003 | US6645967 Arylpiperazines having activity at the serotonin 1A receptor | 
| 11/11/2003 | US6645966 Reverse malaria drug resistance | 
| 11/06/2003 | US20030207896 Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts | 
| 11/06/2003 | US20030207887 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives | 
| 11/06/2003 | US20030207859 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections | 
| 11/05/2003 | EP1358165A1 Imidazole derivatives | 
| 11/05/2003 | EP1358154A2 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases | 
| 11/05/2003 | EP1153006B1 Stabilised compositions of o- and n-vinyl compounds and the use of ammonium salts as stabilisers | 
| 11/05/2003 | EP1019047B1 Antithrombotic agents | 
| 11/05/2003 | CN1454086A High affinity small molecule C5A receptor modulators | 
| 11/04/2003 | US6642229 3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors | 
| 11/04/2003 | US6642223 Benzoheterocyclic derivatives | 
| 10/30/2003 | WO2003088908A2 Heterocyclo inhibitors of potassium channel function | 
| 10/30/2003 | US20030203913 Beta3 adrenergic receptor agonists and uses thereof | 
| 10/30/2003 | US20030203904 Antitumor agents for treating cancer | 
| 10/30/2003 | US20030203889 Phenylsulphonyl derivatives as 5-HT receptor ligands | 
| 10/29/2003 | EP1357134A2 Catalyst compositions for the polymerization of olefins | 
| 10/29/2003 | EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor | 
| 10/29/2003 | EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors | 
| 10/29/2003 | EP1355881A2 An improved process for preparing pure ondansetron hydrochloride dihydrate | 
| 10/29/2003 | EP1355645A2 Method for treating fibrotic diseases or other indications iiic | 
| 10/29/2003 | EP1153920B1 Quinoline derivatives and quinazoline derivatives | 
| 10/29/2003 | EP1089964B1 Hydrazine derivatives | 
| 10/29/2003 | CN1125653C Pharmaceutical formulations containing voriconazole | 
| 10/28/2003 | US6639074 Reacting an alpha -substituted ketone with a cyclic alkylenetetramine in solvent(s) to form a quaternary ammonium salt; reacting with acid in solvent(s) form an alpha -amino ketone; reacting with acyl derivative; dehydrating | 
| 10/28/2003 | US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine | 
| 10/28/2003 | US6638926 Pyrazole compounds useful as protein kinase inhibitors | 
| 10/28/2003 | US6638321 Oxidation color dyes for hair from aniline compounds | 
| 10/23/2003 | WO2003087111A1 Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates | 
| 10/23/2003 | WO2003087110A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof | 
| 10/23/2003 | WO2003087106A1 Derivatives of 2,2,4-trisubstituted tetrahydrofuran as antifungal agents | 
| 10/23/2003 | WO2003087086A2 Substituted indoles | 
| 10/23/2003 | WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents | 
| 10/23/2003 | WO2003087037A1 Substituted aryl amides | 
| 10/23/2003 | WO2003086390A1 Imidazole compounds as anti-inflammatory and analgesic agents | 
| 10/23/2003 | WO2003086271A2 Azole derivatives as antifungal agents | 
| 10/23/2003 | US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy | 
| 10/23/2003 | US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia | 
| 10/23/2003 | US20030199547 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent | 
| 10/23/2003 | US20030199530 New compounds derived from quinazoline | 
| 10/23/2003 | US20030199501 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia | 
| 10/23/2003 | CA2482656A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof | 
| 10/23/2003 | CA2482382A1 Pyrazole compounds as anti-inflammatory and analgesic agents | 
| 10/23/2003 | CA2481532A1 Imidazole compounds as anti-inflammatory and analgesic agents | 
| 10/23/2003 | CA2480856A1 Substituted aryl amides | 
| 10/22/2003 | EP1353916A2 Pyrazole compounds useful as protein kinase inhibitors | 
| 10/22/2003 | EP1353915A2 Therapeutic chroman compounds | 
| 10/22/2003 | EP1353914A2 Therapeutic chromone compounds | 
| 10/22/2003 | EP1353913A2 Therapeutic heterocyclic compounds | 
| 10/22/2003 | EP1353895A2 Primary intermediates for oxidative coloration of hair | 
| 10/22/2003 | EP1066022B1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods | 
| 10/22/2003 | EP0881218B1 Preventives/remedies for complications of diabetes | 
| 10/22/2003 | CN1450999A Novel piperazine derivatives | 
| 10/22/2003 | CN1450990A Inhibitors of neuraminidases | 
| 10/22/2003 | CN1125046C Butadiene derivatives and process for preparing thereof | 
| 10/22/2003 | CN1125023C Substance for inducing cell death | 
| 10/21/2003 | US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis | 
| 10/21/2003 | CA2103894C Aryl sulphonyl urea compounds, a method of preparing them, and their use as herbicides and growth regulators | 
| 10/16/2003 | WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation | 
| 10/16/2003 | WO2003047512A3 Compounds derived from an amine nucleus and pharmaceutical compositions comprising same | 
| 10/16/2003 | US20030195362 For therapy of retroviral infection and in particular an HIV infection | 
| 10/16/2003 | US20030195190 For therapy of allergic rhinitis, ulcer or anorexia, diabetes, Alzheimer's disease, narcolepsy or attention deficit disorder | 
| 10/16/2003 | US20030195185 For therapy of cough, pain, anxiety, asthma, depression or alcohol abuse | 
| 10/16/2003 | US20030195173 Colchinol derivatives as angiogenesis inhibitors | 
| 10/16/2003 | US20030192132 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds | 
| 10/15/2003 | EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases | 
| 10/15/2003 | EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases | 
| 10/15/2003 | EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases | 
| 10/15/2003 | EP1351946A2 Materials and methods to potentiate cancer treatment | 
| 10/15/2003 | EP1268471B1 N-heterocyclic derivatives as nos inhibitors | 
| 10/15/2003 | EP0972768B1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same | 
| 10/15/2003 | EP0861246B1 Prolyl endopeptidase inhibitors, their preparation and their pharmaceutical use | 
| 10/15/2003 | EP0855391B1 Novel isoquinoline derivatives | 
| 10/15/2003 | EP0766674B1 New hiv protease inhibitors | 
| 10/15/2003 | EP0763032B1 Palladium catalyzed ring closure of triazolyl tryptamine | 
| 10/15/2003 | EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives | 
| 10/15/2003 | CN1449395A Process for preparing azacycloalkanoyl aminothiazoles | 
| 10/15/2003 | CN1449388A Process and intermediates for preparing retroviral protease inhibitors | 
| 10/15/2003 | CN1124267C Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides | 
| 10/14/2003 | US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them | 
| 10/14/2003 | US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades | 
| 10/14/2003 | US6632809 Gyrase inhibitors and uses thereof |